MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...

Hidden food sensitivities cause delayed immune reactions that escape allergy tests but trigger chronic inflammation and ...

Approval was based on results from the Phase II TROPION-Lung05 trial, which showed that Datroway demonstrated a strong ...

Early Phase I results for JNJ-79635322 demonstrated an 86.1% overall response rate in heavily pretreated multiple myeloma ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

The combo therapy demonstrated an ORR of 87%, with a complete response rate of 65% and a partial response rate of 23%.

At EHA 2025, the preliminary results from the global, multi-centre open-label non-randomised Phase II RedirecTT-1 clinical ...